These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34288235)

  • 1. Antitumor effects of 3-bromoascochlorin on small cell lung cancer via inhibiting MAPK pathway.
    Zhang Z; Zhang Y; Yang C; Wang Q; Wang H; Zhang Y; Deng W; Nie Y; Liu Y; Luo X; Huang J; Wang J
    Cell Biol Int; 2021 Nov; 45(11):2380-2390. PubMed ID: 34288235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Soft Coral-Derived Compound, 11-Dehydrosinulariolide, Induces G2/M Cell Cycle Arrest and Apoptosis in Small Cell Lung Cancer.
    Lin YC; Su JH; Lin SC; Chang CC; Hsia TC; Tung YT; Lin CC
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30513611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
    Wang H; Zhang X; Vidaurre I; Cai R; Sha W; Schally AV
    Int J Cancer; 2018 Jun; 142(11):2394-2404. PubMed ID: 29435973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
    Wan J; Wu W
    J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells.
    Tang X; Zheng Y; Jiao D; Chen J; Liu X; Xiong S; Chen Q
    Anticancer Agents Med Chem; 2021; 21(6):747-755. PubMed ID: 32682383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer.
    Li H; Liu Y; Liu X; Zhao D; Liu J; Cheng Y
    Anticancer Drugs; 2020 Nov; 31(10):1057-1064. PubMed ID: 32694423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
    Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
    Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
    Cristea S; Sage J
    J Thorac Oncol; 2016 Aug; 11(8):1233-1241. PubMed ID: 27133774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
    Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
    Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
    Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
    Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.
    Tong J; Lu J; Yin Y; Wang Y; Zhang K
    Technol Cancer Res Treat; 2020; 19():1533033820977546. PubMed ID: 33302819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol inhibits viability and induces apoptosis in the small‑cell lung cancer H446 cell line via the PI3K/Akt/c‑Myc pathway.
    Li W; Li C; Ma L; Jin F
    Oncol Rep; 2020 Nov; 44(5):1821-1830. PubMed ID: 32901891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53.
    Zandi R; Selivanova G; Christensen CL; Gerds TA; Willumsen BM; Poulsen HS
    Clin Cancer Res; 2011 May; 17(9):2830-41. PubMed ID: 21415220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK/ERK signaling pathway.
    Sun Y; Lan M; Chen X; Dai Y; Zhao X; Wang L; Zhao T; Li Y; Zhu J; Zhang X; Jiang H; Wu X; Chen C; Zhang T; Yan Z
    Biomed Pharmacother; 2018 Aug; 104():817-824. PubMed ID: 29703569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein exhibits anti-cancer effects via down-regulating FoxM1 in H446 small-cell lung cancer cells.
    Tian T; Li J; Li B; Wang Y; Li M; Ma D; Wang X
    Tumour Biol; 2014 May; 35(5):4137-45. PubMed ID: 24379139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
    Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.